Mark Stanley Berger
Chief Medical Officer · Genprex, Inc.
Individual
- 2024
- Feb 27, 2026
- 3
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark Stanley Berger files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brent M. Longnecker - $22 in GNPX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Stanley Berger?
Mark Stanley Berger is a corporate insider, tracked as Chief Medical Officer of Genprex, Inc. (GNPX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mark Stanley Berger last file a Form 4?
The most recent primary Form 4 on record is dated 27 February 2026, one of 3 filings going back to 2024.
